Vancomycin: A Glycopeptide Antimicrobial with Minimal Systemic Absorption when Taken Orally – Drug Insights and Market Forecast 2023-2032 – Focus on US, Germany, France, Italy, Spain, UK, and Japan

DUBLIN, Nov. 20, 2023 /PRNewswire/ — The “Vancomycin Drug Insight and Market Forecast – 2032” report has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive insights about vancomycin for clostridium difficile infection (CDI) in the seven major markets. A…